India Neurology Devices Market Overview
As per MRFR analysis, the India Neurology Devices Market Size was estimated at 0.73 (USD Billion) in 2023.The India Neurology Devices Market is expected to grow from 1.2(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The India Neurology Devices Market CAGR (growth rate) is expected to be around 10.221% during the forecast period (2025 - 2035).
Key India Neurology Devices Market Trends Highlighted
The rising incidence of neurological conditions, improvements in medical technology, and rising healthcare costs are driving a number of significant developments in the Indian neurology devices market. The need for cutting-edge neurology devices is being driven in large part by the increase in disorders including stroke, epilepsy, and neurodegenerative conditions like Parkinson's and Alzheimer's.
Government health reports state that the significant burden of these illnesses is driving both the public and commercial sectors to invest in the development of cutting-edge diagnostic and therapeutic tools, which has increased the use of neurostimulation devices and minimally invasive procedures.
Opportunities in this market should also be investigated, such as the continuous development of India's healthcare system, especially in rural regions, which gives producers of neurology devices access to a larger patient base.
It is also significant that telemedicine and digital health solutions are becoming more popular since they allow for remote monitoring and consultation, which eventually improves patient care for neurological disorders.
India's focus on increasing domestic manufacturing through programs like "Make in India" further promotes regional neurological device production, which can increase patient accessibility and affordability.
Increased cooperation between manufacturers and tech companies has resulted in the creation of smart devices that integrate data analytics and artificial intelligence, according to recent trends in the India neurology devices market. These developments increase treatment results in addition to increasing diagnostic precision.
Additionally, the Indian population's growing awareness of neurological health encourages patients to advocate for improved treatment alternatives, which advances the industry. All things considered, the changing environment bodes well for the Indian neurology devices market, with a number of factors influencing its course of expansion.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Neurology Devices Market Drivers
Increasing Prevalence of Neurological Disorders
India is witnessing a notable rise in the incidence of neurological disorders, significantly driving the India Neurology Devices Market. Reports indicate that around 6 to 7 million people suffer from epilepsy in India, resulting in an increased demand for devices such as neurostimulators and diagnostic equipment.
Moreover, according to the Indian Council of Medical Research, there has been a 10% annual increase in reported cases of neurological conditions over the past five years. With the population of over 1.4 billion, as recorded in the 2021 Census of India, and a growing elderly demographic, the pressure on healthcare systems to address these conditions is intensifying.
Leading companies like GE Healthcare and Siemens Healthineers are ramping up their R&D efforts to develop innovative neurology devices, providing crucial support to the healthcare sector and shaping the evolution of the India Neurology Devices Market.
Advancements in Technology and Innovation
Technological advancements play a vital role in bolstering the India Neurology Devices Market. Innovations such as minimally invasive surgical techniques are gaining traction, improving outcome rates for patients with neurological disorders.
A study by the Department of Health Research in India highlighted that there has been a 25% increase in the adoption of image-guided neurosurgery in the last three years. Additionally, companies like Medtronic and Johnson & Johnson are continuously investing in Research and Development to enhance neurostimulation devices, which are critical in treating conditions like Parkinson's disease.
The influx of startups focused on neurology innovations is also contributing to a dynamic market environment, leading to further growth in the India Neurology Devices Market.
Government Initiatives and Support
The Indian government has implemented various initiatives aimed at improving healthcare infrastructure, significantly influencing the growth of the India Neurology Devices Market. The National Health Mission and Ayushman Bharat schemes are designed to increase access to healthcare services, emphasizing neurological care.
According to the Ministry of Health and Family Welfare, the government has allocated over 370 billion INR for health initiatives in the recent budget, facilitating improvements in hospital facilities and availability of medical devices.
Additionally, collaborations between government bodies and private organizations are fostering a supportive ecosystem for the development of advanced neurology devices, providing a significant boost to the India Neurology Devices Market.
India Neurology Devices Market Segment Insights
Neurology Devices Market Product Type Insights
The India Neurology Devices Market is experiencing a significant evolution, driven by advancements in technology and an increasing prevalence of neurological disorders. Within the Product Type segment, the market comprises various crucial areas, including neurostimulation, interventional neurology, cerebrospinal fluid (CSF) management, and neurosurgery devices.
Neurostimulation has emerged as a dominant force, addressing conditions such as epilepsy and chronic pain, and offers improved patient outcomes with less invasive approaches. The interventional neurology segment is also critical, facilitating procedures like thrombectomy and stent placement, which are essential in treating stroke patients.
CSF management devices play a vital role in addressing conditions like hydrocephalus, ensuring the proper flow and drainage of cerebrospinal fluid which is crucial for brain health. Lastly, the neurosurgery devices segment encompasses a range of surgical tools and implantable devices providing advanced solutions for complex surgical interventions.
The considerable investments in Research and Development (R&D) by both public and private sectors in India further underpin the growth of the India Neurology Devices Market, fostering innovative solutions tailored to the unique needs of the Indian population.
Additionally, increasing healthcare expenditure and government initiatives aimed at enhancing healthcare infrastructure are contributing to the strong demand within this segment. The rising awareness of neurological conditions among the population, coupled with educational campaigns on early diagnosis and treatment, is also propelling market growth.
Overall, the Product Type segment reflects a detailed landscape of opportunities driven by technological advancements, regulatory support, and an ever-evolving understanding of neurological health challenges in India.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Neurology Devices Market End-user Insights
The End-user segment of the India Neurology Devices Market plays a critical role in the overall growth of the industry. Hospitals and clinics are essential as they provide primary healthcare services and advanced neurological treatments.
The increasing incidence of neurological disorders in India has heightened the demand for effective diagnostic and therapeutic equipment, making hospitals a vital segment in the market. Meanwhile, specialty centers focus on specialized neurological care, including surgeries and rehabilitation, thus driving technological advancements and innovation in devices.
These centers cater to complex cases and offer tailored treatments, which are becoming increasingly significant in a country where patients seek faster and more efficient healthcare solutions. The growing elderly population in India, coupled with rising awareness about neurological conditions, supports further growth and development in these facilities.
Additionally, advancements in technology and increased healthcare spending contribute to the strengthening of these segments, ensuring that they remain pivotal in the evolving landscape of the India Neurology Devices Market.
As they adapt to new treatments and technologies, both hospitals and specialty centers are pivotal in shaping the future of neurological care in India, effectively addressing a wide range of health issues and enhancing patient outcomes.
India Neurology Devices Market Key Players and Competitive Insights
The India Neurology Devices Market is characterized by a dynamic competitive landscape driven by technological advancements and increasing investments in healthcare.
As the healthcare infrastructure in India continues to evolve, the demand for innovative neurology devices is rising, propelled by factors such as an increase in neurological disorders, heightened awareness about mental health, and the government’s focus on improving healthcare services.
Various companies are competing to capture market share by introducing advanced products and improving existing offerings, thus fostering an environment of innovation and competition. Additionally, collaborations, partnerships, and strategic alliances play a crucial role in determining the competitive dynamics as companies seek to enhance their market presence through various channels.
ZymeQuest has established itself as a notable player within the India Neurology Devices Market, primarily due to its specialized focus on developing innovative medical devices designed to address neurological conditions.
The company leverages cutting-edge technology and a strong R&D base, allowing it to launch products that cater specifically to the needs of neurological patients in India. ZymeQuest's strengths lie in its ability to respond quickly to market demands and regulatory changes, alongside its commitment to quality and efficacy.
By fostering strategic collaborations and maintaining a robust supply chain, ZymeQuest has effectively positioned itself to capitalize on the growing demand for neurology devices, gaining a competitive edge in the Indian market.
Abbott Laboratories is a well-established player in the India Neurology Devices Market, known for its comprehensive portfolio of products that target various neurological conditions. Key offerings include advanced neurostimulation devices, imaging technologies, and diagnostic tools tailored for the Indian healthcare landscape.
Abbott Laboratories benefits from a strong brand reputation and extensive distribution network, enabling it to effectively reach healthcare professionals and institutions across the country. The company's ability to innovate and adapt its product offerings in response to local needs is a significant strength, contributing to its solid market presence.
Over the years, Abbott Laboratories has executed strategic mergers and acquisitions aimed at enhancing its technological capabilities and expanding its service offerings. This proactive approach ensures that it remains competitive in a rapidly evolving market, aligning with the growing demands of neurological healthcare in India.
Key Companies in the India Neurology Devices Market Include:
- ZymeQuest
- Abbott Laboratories
- Johnson & Johnson
- Stimwave
- B. Braun
- LivaNova
- NICO Corporation
- NeuroPace
- Boston Scientific
- Stryker
- Medtronic
- ElectroCore
- Cerenovus
- Haemonetics
- Medytox
India Neurology Devices Market Developments
The India Neurology Devices Market has seen significant developments recently, with major players such as Abbott Laboratories, Johnson and Johnson, and Medtronic actively expanding their product lines and enhancing their market presence.
In July 2023, it was reported that Medtronic had announced a new range of implantable devices aimed at treating various neurological disorders in India, reflecting the growing demand for advanced healthcare solutions. Similarly, Boston Scientific and Stryker have been investing in Research and Development to innovate product offerings tailored to Indian patients.
Furthermore, recent mergers and acquisitions continue to shape the market landscape. In August 2023, it was announced that ZymeQuest acquired a division of LivaNova focused on trauma and neurologic products, strengthening ZymeQuest's portfolio in India.
Recent growth has also been noted, with the market valuation for neurology devices experiencing a steady increase, attributed to the rising incidence of neurological disorders in the country. The last couple of years have witnessed an upward trajectory in the market as more companies establish local manufacturing units, thus enhancing accessibility and affordability of neurology devices for the Indian population.
India Neurology Devices Market Segmentation Insights
Neurology Devices Market Product Type Outlook
- neurostimulation
- interventional neurology
- CSF management
- neurosurgery devices
Neurology Devices Market End-user Outlook
- hospitals & clinics
- specialty center
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
0.73(USD Billion) |
MARKET SIZE 2024 |
1.2(USD Billion) |
MARKET SIZE 2035 |
3.5(USD Billion) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
10.221% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Billion |
KEY COMPANIES PROFILED |
ZymeQuest, Abbott Laboratories, Johnson & Johnson, Stimwave, B. Braun, LivaNova, NICO Corporation, NeuroPace, Boston Scientific, Stryker, Medtronic, ElectroCore, Cerenovus, Haemonetics, Medytox |
SEGMENTS COVERED |
Product Type, End User |
KEY MARKET OPPORTUNITIES |
Growing aging population, Increasing neurological disease prevalence, Advancements in minimally invasive technologies, Rising healthcare expenditure, Expanding telemedicine and remote monitoring |
KEY MARKET DYNAMICS |
aging population, rising neurological disorders, increasing healthcare expenditure, advancements in technology, growing awareness and diagnosis |
COUNTRIES COVERED |
India |
Frequently Asked Questions (FAQ) :
The India Neurology Devices Market is expected to be valued at 1.2 billion USD in 2024.
By 2035, the India Neurology Devices Market is projected to grow to 3.5 billion USD.
The expected CAGR for the India Neurology Devices Market from 2025 to 2035 is 10.221%.
The neurostimulation segment holds the largest market share, valued at 0.48 billion USD in 2024.
The neurostimulation market is expected to grow to 1.4 billion USD by 2035.
Major players in the India Neurology Devices Market include Abbott Laboratories, Medtronic, and Boston Scientific.
The interventional neurology segment is valued at 0.3 billion USD in 2024.
The CSF management segment is expected to grow to 0.7 billion USD by 2035.
Several challenges include regulatory hurdles and the need for technological advancements in neurology devices.
Emerging trends include advancements in neurostimulation technology and increased investment in research and development.